Opaleye Management Inc. - 26 May 2021 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Issuer symbol
ETON
Transactions as of
26 May 2021
Net transactions value
-$847,350
Form type
4
Filing time
17 Jun 2021, 16:39:13 UTC
Previous filing
27 May 2021
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale $815,070 -101,000 -2.8% $8.07 3,551,100 15 Jun 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale $32,280 -4,000 -2.7% $8.07 141,600 15 Jun 2021 By Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.